Eating Disorders
Psychiatry·MeSH: Feeding and Eating Disorders
Prevalence
234.5 / 100K
Incidence
236.3 / 100K/yr
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| psilocybin | Kaya Holdings, Inc. (KAYS) |
Frequently asked questions
How many drugs are in development for Eating Disorders?
BioSniper tracks 1 drug in development for Eating Disorders across 1 company.
How many clinical trials target Eating Disorders?
There are 5 clinical trials targeting Eating Disorders tracked by BioSniper.
What is the prevalence of Eating Disorders?
The estimated prevalence of Eating Disorders is approximately 234.5 per 100,000 population.
Deep-dive into Eating Disorders
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis